Rising antimicrobial resistance: a strong reason to reduce excessive antimicrobial consumption in New Zealand

N Z Med J. 2014 May 23;127(1394):72-84.

Abstract

Steadily rising rates of antimicrobial resistance, in a range of common bacterial pathogens, are a major threat to human health in New Zealand in the near future. The single largest contributor to this threat is the high level of antimicrobial consumption in New Zealand. Antimicrobial consumption in New Zealand needs to be reduced if we are to slow the spread of antimicrobial-resistant bacteria. Reporting the per capita antimicrobial consumption within each District Health Board (DHB), in relation to targets for reductions from present levels of consumption, could provide an impetus for DHBs to address this threat to the health of their populations.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Anti-Bacterial Agents / therapeutic use*
  • Bacterial Infections / diagnosis
  • Bacterial Infections / drug therapy
  • Bacterial Infections / epidemiology
  • Community-Acquired Infections / diagnosis
  • Community-Acquired Infections / drug therapy*
  • Drug Resistance, Bacterial*
  • Drug Utilization / statistics & numerical data*
  • Female
  • Humans
  • Incidence
  • Male
  • Microbial Sensitivity Tests
  • Needs Assessment
  • New Zealand
  • Risk Assessment

Substances

  • Anti-Bacterial Agents